Artificial intelligence differentiates cancer cells and detects early viral infections

Full Article

Researchers at the Centre for Genomic Regulation and affiliated institutions have developed AINU, an AI tool capable of distinguishing cancer cells from normal cells and detecting early viral infections. This innovative technology utilizes high-resolution imaging techniques to analyze cellular structures at nanoscale resolution, enabling the identification of subtle changes that traditional methods might miss. The findings, published in Nature Machine Intelligence, promise to enhance diagnostic accuracy and treatment personalization in medical settings.

AINU employs a convolutional neural network to analyze images of cell nuclei, learning to recognize patterns indicative of cancerous changes. The AI's ability to detect alterations as soon as one hour after viral infection could significantly expedite diagnosis and treatment development. While challenges remain in clinical application, the potential for AINU to improve patient outcomes and accelerate scientific research is substantial.

• AINU can differentiate cancer cells from normal cells with high accuracy.

• The AI detects early viral infections within one hour of cell alteration.

Key AI Terms Mentioned in this Article

Convolutional Neural Network

AINU utilizes this technology to analyze high-resolution images of cell nuclei for cancer detection.

Nanoscale Resolution

This resolution allows AINU to identify cellular changes that are imperceptible to traditional imaging methods.

STORM Imaging

AINU relies on STORM imaging to obtain the detailed images necessary for accurate analysis.

Companies Mentioned in this Article

Centre for Genomic Regulation

The Centre is pivotal in developing AINU, which enhances cancer diagnostics.

University of the Basque Country

The university collaborates in the development of AINU, contributing to advancements in medical diagnostics.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics